Thomas White International’s Integra LifeSciences IART Stock Holding History

Thomas White International’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-170	Closed	-$7K	–	281
2017 Q1	$7K	Hold	170	–	–	﹤0.01%	265
2016 Q4	$7K	Hold	170	–	–	﹤0.01%	261
2016 Q3	$7K	Sell	170 -80	-32%	-$3.35K	﹤0.01%	228
2016 Q2	$10K	Sell	250 -560	-69%	-$20.1K	﹤0.01%	199
2016 Q1	$27K	Hold	810	–	–	﹤0.01%	202
2015 Q4	$27K	Hold	810	–	–	﹤0.01%	215
2015 Q3	$24K	Sell	810 -181	-18%	-$5.66K	﹤0.01%	251
2015 Q2	$27K	Buy	991 +330	+50%	+$8.79K	﹤0.01%	255
2015 Q1	$17K	Hold	661	–	–	﹤0.01%	264
2014 Q4	$15K	Hold	661	–	–	﹤0.01%	278
2014 Q3	$13K	Hold	661	–	–	﹤0.01%	275
2014 Q2	$13K	Buy	+661	New	+$12.3K	﹤0.01%	291

Other funds holding IART

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Thomas White International's IART Position: Q2 2017 in Review

Thomas White International sold out of Integra LifeSciences (IART) in Q2 2017, closing a stake of 170 shares — an estimated $7K sold.

Thomas White International first reported a position in IART in Q2 2014 and held it in 12 quarters. The position peaked at $27K in Q1 2016. 223 funds tracked by Wall St. Rank hold IART as of Q2 2017.

Thomas White International reported no remaining Integra LifeSciences position as of Q2 2017 after selling out during the quarter.
Thomas White International sold 170 Integra LifeSciences shares in Q2 2017, an estimated $7K.
Thomas White International first reported a position in Integra LifeSciences in Q2 2014 and held it in 12 quarters.
Thomas White International's Integra LifeSciences position peaked at $27K in Q1 2016.
223 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2017.

Based on Thomas White International's 13F filing for Q2 2017, filed 8 Aug 2017.